Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 1, 1996, Pages 20-23

  Rapeport, William G ^a   Williams, Stephen A ^a   Muirhead, David C ^a   Dewland, Peter M ^b   Tanner, Trevor ^b   Wesnes, Keith ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b SIMBEC RESEARCH LTD   (United Kingdom)

^c Harvard Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MUSCLE WEAKNESS; NAUSEA; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO; VOMITING;

1-NAPHTHYLAMINE; ADULT; CARBAMAZEPINE; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; HUMANS; MALE; PLACEBOS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0029918465     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rail TW, Schleifer LS. Drugs effective in the therapy of the epilepsies. In: Goodman AG, Rail TW, Nies AS, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Pergamon Press: 1990:436-462
2. Brodie MJ. Drag interactions in epilepsy. Epilepsia 1992;33(suppl 1): S13-S22
3. Pearson HJ. Interaction of fluoxetine with carbamazepine [letter]. J Clin Psychiatry 1990;51:126
4. Grimsley SR, Jann MW, Carter JG, et al. Increased carbamazepine plasma concentrations after fluoxetine coadministration. Clin Pharmacol Ther 1991:50:10-15
5. Fritze J, Unsorg B, Lanczik M. Interaction between carbamazepine and fluvoxamine. Acta Psychiatr Scand 1991;84:583-584
6. Spina E, Avenoso A, Pollicino AM, et al. Carbamazepine coadministration with fluoxetine or fluvoxamine. Ther Drug Monit 1993;15: 247-250
7. van Harten J, Stevens L, Raghoebar M, et al. Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 1992;52:427-435
8. Wesnes K, Simpson PM, Kidd AG. An investigation of the range of cognitive impairments induced by scopolamine 0.6 mg. Human Psychopharmacology 1988;3:27-43
9. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol 1974;47:211-218
10. Martinelli V, Bocchetta A, Palmar AM, et al. An interaction between carbamazepine and fluvoxamine. Br J Clin Pharmacol 1993;36:615-616
11. Bonnet P, Vandel S, Nezeloff S, et al. Carbamazepine, fluvoxamine. Is there a pharmacokinetic interaction? [letter] Therapie 1992;47:165
12. von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, et al. Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine. Br J Clin Pharmacol 1994;38: 23-31